English
繁體中文
Nov 18, 2022
Why Fentanyl Vaccine Could Be a Game Changer for Opioid Epidemic “Just because we are seeing this breakthrough through an animal-based study does not mean that its efficacy will transfer to humans,” Dr. Emil Tsai, a neuroscientist and founding chief executive officer of biotech developer SyneuRx, told Healthline. “The biological divergence between the species can lead to unreliable results in the transfer. “That unknown aside, there are a few points within the study that I am dubious about,” Tsai said. “It’s unclear why the results were more effective for male rats than for female rats. In addition, the decision to make this drug only respond to fentanyl does little to combat those who are addicted to opioids, as this leaves the possibility for them to seek out other opioid drugs.” Tsai said the vaccine only addresses one part of recovery. “It’s important to treat the entire scope of the addiction,” Tsai said. “Relying on biological methods is a piecemeal solution. It does not address the entire problem. Those who are reliant on drugs or alcohol need counseling and mental wellness for healing.”
Oct 28, 2022
Dr. Tsai shared his commentary about the relationship of dementia and blood pressure and was quoted several times in the article.
Oct 14, 2022
Dr. Tsai shared his commentary about accurate COVID-19 death, and SyneuRx was mentioned.
Oct 12, 2022
Dr. Tsai shared his commentary regarding the new study of ketamine on depression. SyneuRx's website was linked to this article.
Oct 04, 2022
Forbes. Dr. Tsai was interviewed and shared his commentary regarding the polio. "No polio cases have been caused by wild poliovirus originating in the U.S. since 1979 until recently when poliovirus was confirmed in an unvaccinated, [healthy] adult resident of New York,” explains Emil Tsai, M.D., a professor at the David Geffen School of Medicine at UCLA. “Given the facts of transmission, eradication of polio is a misnomer. While polio had been eradicated in the U.S., Afghanistan and Pakistan still have not eliminated the disease, and two years ago, it was imported to East Africa,” he says. “Since there are still pockets of the disease in the world, there is always a risk, and it has happened before that the virus is brought into the country by international travelers.”
Sep 20, 2022
"Twindemic is like a naturally occurring biological weapon against humanity. There are several pharmaceutical therapies in development that have shown great promise in treating a potential twindemic, Pentarlandir® being one." Emil Tsai, MD, PhD, SyneuRx CEO
Sep 14, 2022
Dr. Tsai shared his commentary and was quoted several times in the article about the shortage of ADHD medication.
Sep 02, 2022
SyneuRx CEO Dr. Emil Tsai Exclusive Interview with Insights & Projections
Aug 09, 2022
Taiwan’s Syneurx gears up for phase III test of COVID-19 oral antiviral
Aug 07, 2022
Dr. Tsai was quoted in the article "Depression in Father and Child Are Linked Regardless of Genetic Relation", and SyneuRx was mentioned in the article.
July 05, 2022
Dr. Tsai was quoted in the article "I’m a Virus Expert and It’s Still Dangerous to Go Here"
Jun 27, 2022
Online article contributed by Dr. Tsai: "Here's What Monkeypox Infection Looks Like, Says Doctor Monkeypox is a rare disease, so far, but cases have been rising."
May 27, 2022
Online article contributed by Dr. Tsai: "Virus Expert Says Be Ready for This to Happen Next A new big wave of infection is coming to the U.S."
May 15, 2022
New York Post quoted Dr. Tsai and mentioned Synapsinae and Neuserine in its article “Hope on the Horizon,” about new treatments for depression
Apr 25, 2022
Newsmax.com picked up Dr. Tsai’s quotes from the ETNT article regarding the Symptoms of a BA.2 Infection titled, “COVID-19 Cases Rising: Watch for These Symptoms of a BA.2 Infection”
Apr 20, 2022
Online article contributed by Dr. Tsai: "I’m a Virus Expert and Most People Catch the Virus This Way Now COVID is here to stay, follow this advice and protect yourself from the potentially deadly virus."
Apr 16, 2022
Dr. Tsai was quoted in the article "First Signs of BA.2 Infection, According to Physicians"
Dr. Tsai was quoted in the article "Sure Signs You’ve Already Had COVID, Says Dr. Fauci"
Apr 13, 2022
One News Page posted the “SyneuRx Reaches Target Enrollment in Phase 2 Clinical Trial of COVID-19 Oral Antiviral Candidate Pentarlandir® (SNB01)” press release
Clinical Trials Arena posted the “SyneuRx Reaches Target Enrollment in Phase 2 Clinical Trial of COVID-19 Oral Antiviral Candidate Pentarlandir® (SNB01)” press release
Bloomberg posted the “SyneuRx Reaches Target Enrollment in Phase 2 Clinical Trial of COVID-19 Oral Antiviral Candidate Pentarlandir® (SNB01)” press release
Yahoo Finance posted the “SyneuRx Reaches Target Enrollment in Phase 2 Clinical Trial of COVID-19 Oral Antiviral Candidate Pentarlandir® (SNB01)” press release
Apr 11, 2022
Dr. Tsai was quoted in the article "The #1 Cause of “Severe” COVID Say Experts"
Apr 07, 2022
Dr. Tsai was quoted in the article "Sure Signs You Have an Omicron Infection"
Apr 03, 2022
Dr. Tsai was quoted in the article "Virus Expert Says COVID Symptoms Usually Appear in This Order"
Mar 30, 2022
Q&A with SyneuRx Chief Scientist and CEO, Emil Tsai, MD, PhD, MAS: "What are the top Symptoms of the BA.2 Variant and is it a Major Cause for Concern?"
July 27, 2021
SyneuRx presented at Bio Asia-Taiwan 2021 Conference
Jan 19, 2021
"From CNS Pandemia to Corona Virus Pandemia." By Guochuan Emil Tsai, MD, PhD, MAS.
Mar 29, 2017
Pharma Boardromm: "Interview: Guochuan Emil Tsai MD PhD MAS – Founder & CEO, SyneuRx, Taiwan"
